AGP Picks
View all

The Asia Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Reporter.

Press releases published on November 9, 2026

Curia augmente sa capacité de fermentation à León, en Espagne
קוריה מרחיבה את כושר התסיסה שלה בלאון, ספרד
Curia Memperluas Kapasitas Fermentasi di León, Spanyol
キュリア、スペイン・レオンで発酵能力を拡大
큐리아 (Curia), 스페인 레온 사업장 발효 생산능력 확대
Curia Memperluas Kapasiti Penapaian di León, Sepanyol
Curia Expande Capacidade de Fermentação em León, Espanha
Curia ขยายกำลังการผลิตด้วยการหมักที่เมืองเลออน ประเทศสเปน
Curia 于西班牙莱昂扩大发酵产能
Curia 擴展在西班牙萊昂的發酵產能
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of…
AnorTech Closes Final C$7.55 Million Share Exchange; Nasdaq-Listed Greenland Mines Now Holds 19.9%
Noitom Robotics Releases HiPHI-Hand, Precision Hand Capture Data Used to Train NVIDIA EgoHand, and Demonstrates Real-Time Hand Reconstruction at CoRL 2026
Luda Technology Group Expands Mongolia-China Coal Trading Business with 1.05 Million Metric Ton Agreement with Shanghai Shouying Huifu Energy Development Co., Ltd.
Kinetiq Launches Elysium Public Mainnet, a High-Performance Layer 2 Built for Hyperliquid
Work Commences to Produce NdPr Oxide and NdPr Metal from Halleck Creek Ore
NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues
Biodexa provides R&D Update
Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026
Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Asia Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.